Immatics (IMTX) director entities disclose indirect share and option stakes
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Immatics N.V. received an initial ownership report from investment entities affiliated with Perceptive Advisors. The filing shows that Perceptive Life Sciences Master Fund directly holds 10,383,456 ordinary shares of Immatics, with Perceptive Advisors acting as investment advisor and Joseph Edelman as its managing member.
The report also lists multiple director stock options on Immatics ordinary shares, awarded to Adam Stone for his board service, with exercise prices between $5.44 and $12.00 and expirations from 2030 to 2035. The Master Fund has the right to receive this director compensation through a management fee offset. Perceptive Advisors and Mr. Edelman expressly disclaim beneficial ownership of these securities except to the extent of any indirect pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
PERCEPTIVE ADVISORS LLC, EDELMAN JOSEPH, PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Role
Director | Director | Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Director Stock Option (Right to Buy) | -- | -- | -- |
| holding | Director Stock Option (Right to Buy) | -- | -- | -- |
| holding | Director Stock Option (Right to Buy) | -- | -- | -- |
| holding | Director Stock Option (Right to Buy) | -- | -- | -- |
| holding | Director Stock Option (Right to Buy) | -- | -- | -- |
| holding | Director Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares, nominal value EUR 0.01 per share | -- | -- | -- |
Holdings After Transaction:
Director Stock Option (Right to Buy) — 25,000 shares (Indirect, See Footnote);
Ordinary Shares, nominal value EUR 0.01 per share — 10,383,456 shares (Indirect, See Footnote)
Footnotes (1)
- The securities are directly held by Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund"). Perceptive Advisors, LLC (the "Advisor") serves as the investment advisor to the Master Fund. Joseph Edelman is the managing member of the Advisor. This option was granted on June 30, 2020 and is fully vested. This option was granted on December 9, 2021 and is fully vested. This option was granted on June 24, 2025 and will vest in full on the first anniversary of the grant date. Consists of options to purchase the Issuer's ordinary shares awarded to Adam Stone in connection with his role as a member of the Issuer's board of directors. Mr. Stone is the Chief Investment Officer of the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Master Fund has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset. The Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
FAQ
What does the Immatics (IMTX) Form 3 filed by Perceptive entities show?
The Form 3 lists existing indirect holdings in Immatics by Perceptive Life Sciences Master Fund, including 10,383,456 ordinary shares and director stock options. It establishes their starting beneficial ownership position as board-related investment entities, without recording any new purchases or sales.
What director stock options are reported for Immatics (IMTX) in this filing?
The filing lists several director stock options on Immatics ordinary shares with exercise prices from $5.44 to $12.00 and expiration dates between 2030 and 2035. These options were awarded to Adam Stone in connection with his role on the Immatics board of directors.
Why are Adam Stone’s Immatics (IMTX) options attributed to Perceptive entities?
The options are reported as director compensation for Adam Stone, who is Chief Investment Officer of Perceptive Advisors. The Master Fund has the right to receive this director compensation through a partial management fee offset, so the economic benefit flows to the Perceptive fund structure.
Do Perceptive Advisors LLC and Joseph Edelman claim full beneficial ownership of Immatics (IMTX) securities?
No. Perceptive Advisors and Joseph Edelman expressly disclaim beneficial ownership for Section 16 purposes, except to the extent of any indirect pecuniary interest. The disclosure clarifies that their role is primarily as advisor and managing member to the Master Fund holder.
Does this Immatics (IMTX) Form 3 reflect any insider buying or selling activity?
No new buying or selling activity is indicated. All entries are classified as holdings, with buy and sell counts at zero in the transaction summary. The form functions as an initial statement of beneficial ownership rather than a record of recent trades.